As shown in Figures 4M,N, there was a small amount of tumor-infiltrating CD45+CD3+ cells were detected and no significant difference between the tumor-infiltrating CD8+CD44+ cells gated from CD45+CD3+ cells in all the treatment groups compared with the control group. This evidence concerns the gene PTPRC and neoplasm.